Legislation affecting FDA's regulatory framework for dietary supplements and OTC drugs as well as products across the agency's oversight has little time to pass before Congress essentially halts operations for an extended period, says a House committee staff member.
"Congress basically will come to a screeching halt right around July 15," said Tiffany Guarascio, Energy & Commerce Committee minority...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?